Anti-EGFR antibody [EP38Y]

21 product images

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) staining of human placenta using rabbit Anti-EGFR antibody

  Immunohistochemical analysis of formalin fixed paraffin embedded human placenta labelling EGFR with ab52894 at a concentration of 0.21 µg/ml. The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with a Bond™ Polymer Refine Detection kit. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution 2) for 20 mins. ab52894 Anti-EGFR antibody [EP38Y] was incubated for 30 mins at room temperature. Sections were counterstained with Hematoxylin. Image inset shows absence of staining in secondary antibody only control.

• 

  Immunoprecipitation - Anti-EGFR antibody [EP38Y] (ab52894)

  ab52894 (purified) at 1:20 dilution (0.5 μg) immunoprecipitating EGFR in HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate.
  
  Lane 1 (input): HeLa whole cell lysate 10 μg
  
  Lane 2 (+): ab52894 in HeLa whole cell lysate
  
  Lane 3 (-): Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab52894 in HeLa whole cell lysate
  
  For western blotting, VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) was used for detection at 1:1000 dilution.
  
  Blocking and diluting buffer: 5% NFDM/TBST.

  All lanes: Immunoprecipitation - Anti-EGFR antibody [EP38Y] (ab52894)

  Predicted band size: 134 kDa

  Observed band size: 175 kDa

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFR antibody [EP38Y] (ab52894)

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cervical carcinoma tissue sections labeling EGFR with purified ab52894 at 1:100 dilution (0.95 μg/ml).
  

  Heat mediated antigen retrieval was performed using EDTA buffer, pH 9.0. Tissue was counterstained with hematoxylin. Goat Anti-Rabbit IgG H&L (HRP) ab97051 Goat Anti-Rabbit IgG H&L (HRP) secondary antibody was used at 1:500 dilution. PBS instead of the primary antibody was used as the negative control.

• 

  Western blot - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Western blot staining using rabbit Anti-EGFR antibody

  False colour image of Western blot: Anti-EGFR antibody [EP38Y] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab52894 was shown to bind specifically to EGFR. A band was observed at 160 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in Egfr CRISPR-Cas9 edited cell line Human EGFR knockout HCT116 cell line ab281597 (CRISPR-Cas9 edited cell lysate ab282949). The band observed in the CRISPR-Cas9 edited lysate lane below 160 kDa is likely to represent a truncated form of EGFR. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and Egfr CRISPR-Cas9 edited HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween^® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye^® 800CW) preabsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye^® 680RD) preabsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) at 1/20000 dilution.

  All lanes: Western blot - Anti-EGFR antibody [EP38Y] (ab52894) at 1/1000 dilution

  Lane 1: Wild-type HCT 116 cell lysate at 20 µg

  Lane 2: EGFR CRISPR-Cas9 edited HCT 116 cell lysate at 20 µg

  Lane 3: Caco-2 cell lysate at 20 µg

  Performed under reducing conditions.

  Predicted band size: 134 kDa

  Observed band size: 160 kDa

• 

  Western blot - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Western blot staining using rabbit Anti-EGFR antibody

  > Lanes 1 - 4: Merged signal (red and green). Green - ab52894 observed at 175 kDa. Red - loading control, Anti-Vinculin antibody [VIN-54] ab130007 observed at 125 kDa.
  

  ab52894 was shown to react with EGFR in wild-type HeLa. Loss of signal was observed when knockout cell line Human EGFR knockout HeLa cell line ab255385 (knockout cell lysate Human EGFR knockout HeLa cell lysate ab263845) was used. Wild-type and EGFR knockout samples were subjected to SDS-PAGE. ab52894 and Anti-Vinculin antibody [VIN-54] (Anti-Vinculin antibody [VIN-54] ab130007) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye^® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye^® 680RD) preadsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  All lanes: Western blot - Anti-EGFR antibody [EP38Y] (ab52894) at 1/1000 dilution

  Lane 1: A431 cell lysate at 20 µg

  Lane 2: MDA-MB-468 cell lysate at 20 µg

  Lane 3: Wild-type HeLa cell lysate at 20 µg

  Lane 4: EGFR knockout HeLa cell lysate at 20 µg

  Secondary

  All lanes: Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) at 1/20000 dilution

  Performed under reducing conditions.

  Predicted band size: 134 kDa

  Observed band size: 124 kDa, 134 kDa

• 

  Western blot - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Western blot staining using rabbit Anti-EGFR antibody

  Blocking and diluting buffer: 5% NFDM/TBST

  All lanes: Western blot - Anti-EGFR antibody [EP38Y] (ab52894) at 1/10000 dilution

  Lane 1: Rat liver lysates at 15 µg

  Lane 2: Mouse lung lysates at 15 µg

  Secondary

  All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution

  Predicted band size: 134 kDa

  Observed band size: 175 kDa

• 

  Flow Cytometry (Intracellular) - Anti-EGFR antibody [EP38Y] (ab52894)

  Intracellular Flow Cytometry analysis of A431 (Human epidermoid carcinoma epithelial cell) cells labeling EGFR with purified ab52894.
  

  Cells were fixed with 4% paraformaldehyde (10 mins) and permeabilized with 90% methanol for 30 mins. Then incubated in 1x PBS / 10% normal goat serum to block non-specific protein-protein interactions followed by ab52894 at 1/20 dilution (red) for 30 mins. A Goat anti rabbit IgG (Alexa Fluorr^® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

• 

  Western blot - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Western blot staining of HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates using rabbit Anti-EGFR antibody

  Blocking and diluting buffer: 5% NFDM/TBST

  All lanes: Western blot - Anti-EGFR antibody [EP38Y] (ab52894) at 1/2000 dilution

  All lanes: HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 20 µg

  Secondary

  All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution

  Predicted band size: 134 kDa

  Observed band size: 175 kDa

• 

  Immunocytochemistry/ Immunofluorescence - Anti-EGFR antibody [EP38Y] (ab52894)

  Immunocytochemistry/ Immunofluorescence analysis of A431 (Human epidermoid carcinoma epithelial cell) cells labeling EGFR with purified ab52894 at 1:250 dilution (0.4 μg/ml).
  

  Cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Cells were counterstained with Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor^® 594) 1:200 (2.5 μg/ml). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077 Goat anti rabbit IgG(Alexa Fluor^® 488) was used as the secondary antibody at 1:1000 dilution. DAPI nuclear counterstain.

  PBS instead of the primary antibody was used as the secondary antibody only control.

• 

  Indirect ELISA - Anti-EGFR antibody [EP38Y] (ab52894)

  ELISA analysis of Human EGFR recombinant protein at 1000 ng/ml with ab52894. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution was used as the secondary antibody.

• 

  Western blot - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Western blot staining using rabbit Anti-EGFR antibody

  This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 mins before being transferred onto a Nitrocellulose membrane at 30V for 70 mins. The membrane was then blocked for an hour before being incubated with unpurified ab52894 overnight at 4°C in the presence of loading control ab18058 (Mouse monoclonal [SPM227] to Vinculin diluted 1:10000). Antibody binding was detected using IR-labeled goat anti-Rabbit Ab at a 1:10,000 dilution for one hour at room temperature before imaging.
  

  This product yielded a strong signal in western blot using A431 (human squamous carcinoma) lysate which naturally overexpresses the EGFR protein. Western blot conditions may need to be optimised for cell lines and tissues that express lower levels of endogenous EGFR.

  All lanes: Western blot - Anti-EGFR antibody [EP38Y] (ab52894) at 1/1000 dilution

  Lane 1: Caco-2 (Human colorectal adenocarcinoma cell line) cell lysate at 20 µg

  Lane 2: A431 (Human epidermoid carcinoma cell line) cell lysate at 20 µg

  Lane 3: Mouse skin cell lysate at 20 µg

  Lane 4: Rat skin cell lysate at 20 µg

  Performed under reducing conditions.

  Predicted band size: 134 kDa

• 

  OI-RD Scanning - Anti-EGFR antibody [EP38Y] (ab52894)

  We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody.
  Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

• 

  Western blot - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Western blot staining using rabbit Anti-EGFR antibody

  Different batches of ab52894 were tested on HeLa (Human cervix adenocarcinoma epithelial cell) lysate at 1.0 µg/ml. 15 µg of lysate was loaded in each lane. Bands observed at 175 kDa.

  All lanes: Western blot - Anti-EGFR antibody [EP38Y] (ab52894)

  Predicted band size: 134 kDa

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) staining using rabbit Anti-EGFR antibody

  Tissue microarrays stained for Anti-EGFR antibody [EP38Y] using ab52894 in immunohistochemical analysis. This table provides a detailed overview of positive (tick mark) and negative (cross mark) staining per sample type tested. The sections were pre-treated using heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins. The section was incubated with ab52894 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument

• 

  Immunocytochemistry/ Immunofluorescence - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Immunocytochemistry/ Immunofluorescence staining using rabbit Anti-EGFR antibody

  ab52894 staining of EGFR in a HCT116 cell spheroid. The cells were fixed with 4% formaldehyde (10 min), permeabilised with 0.5% Triton X-100 for 1h and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween overnight at room temperature. The spheroids were then incubated overnight at room temperature with ab52894 at 2 μg/ml and Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291, Mouse monoclonal [DM1A] to alpha Tubulin at 2 μg/ml. DAPI was used as nuclear counterstain (shown in blue). As secondary antibodies Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat anti-Rabbit (Alexa Fluor^® 488) (shown in green) and Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed ab150120 Goat anti-Mouse (Alexa Fluor^® 594) (shown in magenta) were used, incubated overnight at room temperature. All permeabilization, blocking and antibody incubation steps were performed using a rotary shaker.

  Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.

  The antibody ab52894 also worked using 100% methanol (5 min).

• 

  Western blot - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Western blot staining using rabbit Anti-EGFR antibody

  Western blot: Anti-EGFR antibody [EP38Y] (ab52894) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab52894 was shown to bind specifically to EGFR. A band was observed at 175 kDa in wild-type A549 cell lysates with no signal observed at this size in EGFR knockout cell line. To generate this image, wild-type and EGFR knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

  All lanes: Western blot - Anti-EGFR antibody [EP38Y] - BSA and Azide free (Anti-EGFR antibody [EP38Y] - BSA and Azide free ab272293)

  Lane 1: Wild-type A549 cell lysate at 20 µg

  Lane 2: EGFR knockout A549 cell lysate at 20 µg

  Lane 3: Wild-type HeLa cell lysate at 20 µg

  Lane 4: EGFR knockout HeLa cell lysate at 20 µg

  Developed using the ECL technique.

  Performed under reducing conditions.

  Observed band size: 175 kDa

• 

  Western blot - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Western blot staining using rabbit Anti-EGFR antibody

  Blocking and diluting buffer and concentration: 5% NFDM/TBST.

  In Western blot, Anti-EGFR (phospho Y845 + Y1068 + Y1086) antibody [RM1132] ab319113 was shown to bind specifically to EGFR. Target of interest was observed at 175kDa, in wild-type HeLa cell lysates (lane 1/2/5/6) with no signal observed at this size in EGFR knockout cell line (lane 3/4/7/8) (knockout cell line Human EGFR knockout HeLa cell line ab255385 / knockout cell lysate Human EGFR knockout HeLa cell lysate ab263845).

  In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.

  In Western blot, Anti-EGFR antibody [EP38Y] (ab52894) staining at 1/1000 dilution.

  All lanes: Western blot - Anti-EGFR (phospho Y845 + Y1068 + Y1086) antibody [RM1132] (Anti-EGFR (phospho Y845 + Y1068 + Y1086) antibody [RM1132] ab319113) at 1/1000 dilution

  Lane 1: Untreated wild-type HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg

  Lane 2: Wild-type HeLa treated with 100ng/ml EGF for 30 minutes whole cell lysate (untreated membrane) at 20 µg

  Lane 3: Untreated EGFR knockout HeLa whole cell lysate (untreated membrane) at 20 µg

  Lane 4: EGFR knockout HeLa treated with 100ng/ml EGF for 30 minutes whole cell lysate (untreated membrane) at 20 µg

  Lane 5: Untreated wild-type HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

  Lane 6: Wild-type HeLa treated with 100ng/ml EGF for 30 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

  Lane 7: Untreated EGFR knockout HeLa whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

  Lane 8: EGFR knockout HeLa treated with 100ng/ml EGF for 30 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg

  Secondary

  All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution

  Performed under reducing conditions.

  Observed band size: 175 kDa, 36 kDa

  Exposure time: 180s

• 

  Western blot - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Western blot staining using rabbit Anti-EGFR antibody

  Blocking and diluting buffer and concentration: 5% NFDM/TBST.

  In Western blot, Anti-Vinculin antibody [EPR8185] (Anti-Vinculin antibody [EPR8185] - Loading Control ab129002) staining at 1/10000 dilution.

  In Western blot, Anti-EGFR antibody [EP38Y] (ab52894) staining at 1/1000 dilution.

  All lanes: Western blot - Anti-EGFR (phospho Y845 + Y1068 + Y1086) antibody [RM1132] (Anti-EGFR (phospho Y845 + Y1068 + Y1086) antibody [RM1132] ab319113) at 1/5000 dilution

  Lane 1: Untreated A431 (human epidermoid carcinoma epithelial cell) whole cell lysate (untreated membrane) at 10 µg

  Lane 2: A431 treated with 100ng/ml EGF for 30 minutes whole cell lysate (untreated membrane) at 10 µg

  Lane 3: Untreated A431 whole cell lysate (alkaline phosphatase treated membrane) at 10 µg

  Lane 4: A431 treated with 100ng/ml EGF for 30 minutes whole cell lysate (alkaline phosphatase treated membrane) at 10 µg

  Secondary

  All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution

  Observed band size: 175 kDa, 124 kDa

  Exposure time: 169s

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) staining of Human glioblastoma tissue using rabbit Anti-EGFR antibody

  Chromogenic duplex (2-plex) immunohistochemical staining of formalin fixed paraffin-embedded human glioblastoma tissue performed on a Roche Ventana Discovery Ultra instrument.

  Heat mediated antigen retrieval was performed with CC1 solution for 64 min at 95°C. Two rounds of primary antibody incubation were performed each for 16 min at 37°C. anti-EGFRvIII (Anti-EGFRvIII antibody [EPR28380-83] ab313646; 1st primary antibody; 3 µg/ml) and anti-EGFR (ab52894; 2nd primary antibody; 0.5 µg/ml). Antibody denaturation was conducted after the first round of staining using Ultra CC2 solution for 8 min at 100°C to avoid cross reactivity.

  Signal was developed with anti-rabbit HQ followed by anti-HQ HRP coupled with purple (Discovery purple kit (RUO) #760-229) and teal (Discovery teal kit (RUO) #760-247) chromogens and counterstained with haematoxylin II.

  Tissue obtained from the Human Research Tissue Bank, supported by the NHR Cambridge Biomedical Research Centre.

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) staining of human placenta using rabbit Anti-EGFR antibody

  Immunohistochemical analysis of formalin fixed paraffin embedded human placenta labelling EGFR with ab52894 at a concentration of 0.1 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with an OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was conducted for 32 mins at 100°C with ULTRA cell conditioning solution (CC1, pH 8.5). ab52894 Anti-EGFR antibody [EP38Y] was incubated at 37°C for 16 mins. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFR antibody [EP38Y] (ab52894)

  EGFR Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) staining of Human glioblastoma and placenta tissues using rabbit Anti-EGFR antibody

  Immunohistochemical analysis of formalin fixed paraffin-embedded human glioblastoma and placenta tissues labelling EGFRvIII with Anti-EGFRvIII antibody [EPR28380-83] ab313646 and EGFR with ab52894 at a concentration of 2.5 µg/ml and 0.5 µg/ml.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with a Bond™ Polymer Refine Detection kit. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution 2) for 20 mins. Primary antibodies were incubated for 30 mins at room temperature. Sections were counterstained with Hematoxylin.

  Tissue obtained from the Human Research Tissue Bank, supported by the NHR Cambridge Biomedical Research Centre.